Agilent Technologies, Inc. - Diagnostics and Genomics SSXT2 CD GlasgowCancerCore, 96 A
The Agilent SureSelectXT2 CD GlasgowCancerCore, 96 A (part number 5191-6734) is a targeted enrichment solution designed for next-generation sequencing (NGS) applications. This product enables researchers to efficiently capture and sequence specific genomic regions associated with cancer, using Agilent's SureSelectXT2 technology. The kit supports high-throughput workflows and is optimized for use with 96 samples, providing comprehensive coverage and reliable performance. It is intended for use in research settings, facilitating the identification and analysis of genetic variants in cancer-related genes.